Medline Inc. R&D Expense 2023-2025 | MDLN
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is Medline Inc.'s current r&d expense?
Medline Inc. (MDLN) annual r&d expense for 2025 was $80.0M, a 19.40% increase from 2024.
What was Medline Inc.'s r&d expense in 2024?
Medline Inc. annual r&d expense for 2024 was $67.0M, a 11.67% increase from 2023.
What was Medline Inc.'s r&d expense in 2023?
Medline Inc. annual r&d expense for 2023 was $60.0M.
What is Medline Inc.'s 2-year r&d expense CAGR?
Medline Inc. r&d expense grew at a compound annual growth rate (CAGR) of 15.47% from FY2023 to FY2025, going from $60.0M to $80.0M over 2 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+15.5%
FY2023
$60.0M
→
FY2025
$80.0M
232425
2 years selected
R&D Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $80.0M | +19.4% | 10-K |
| FY2024 | $67.0M | +11.7% | 10-K |
| FY2023 | $60.0M | - | 10-K |